Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BACLOVILLE: Baclofen in Alcoholism
NCT01604330Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2012
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol use disorder (AUD) comparing Baclofen with Placebo (2 arms). Primary endpoint: Proportion of abstainer patients and patients with a low risk consumption at 12 months. Started May 2012; status: completed.
02
Drugs
baclofen
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01604330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01604330.